Formal Name
Tumor Markers
This article was last reviewed on
This article waslast modified on
May 25, 2018.
What are tumor markers?

Tumor markers are substances, often proteins, that are produced by the cancer tissue itself or sometimes by the body in response to cancer growth. Because some of these substances can be detected in body samples such as blood, urine, and tissue, these markers may be used, along with other tests and procedures, to help detect and diagnose some types of cancer, predict and monitor a person's response to certain treatments, and detect recurrence.

More recently, the idea of what constitutes a tumor marker has broadened. Newer types of tests have been developed that look for changes in genetic material (DNA, RNA), rather than proteins, in patient samples. The genetic changes have been found to be associated with certain cancers and can be used as tumor markers to help determine prognosis, guide targeted treatment, and/or detect cancers early on. Moreover, advances in technology have led to tests that can evaluate several genetic markers or panels of markers at the same time, providing expanded information about characteristics of a tumor. Examples of these are included, along with more traditional tumor markers, in the table within this article.

While quite a few tumor markers are available and have been found to be clinically useful, others are available but not ordered frequently because they have been found to be less sensitive and/or specific. Still others are currently used only in research settings and continue to be evaluated in clinical trials. With ongoing research, and as the field continues to evolve, it is likely that more tumor markers with greater effectiveness will come on the market in the coming years, eventually replacing less useful ones.

Limitations

While tumor marker tests can provide very useful information, they do have limitations:

  • Many tumor markers may also be elevated in persons with diseases other than cancer.
  • Some tumor markers are specific for a particular type of cancer, while others are seen in several different types of cancer.
  • Not every person with a particular type of cancer will have an elevated level of the corresponding tumor marker.
  • Not every cancer has a tumor marker that has been identified as associated with it.

Consequently, tumor markers alone are not diagnostic for cancer; for some types of cancer, they provide additional information that can be considered in conjunction with a patient's medical history and physical exam as well as other laboratory and/or imaging tests.

How are tumor markers used?

Tumor markers may be used for a variety of purposes. However, they are not typically used alone. Depending on the type of cancer, they may be used in conjunction with a tissue biopsy or a bone marrow or blood smear examination, for example, and/or with other tumor markers. They are not definitive but provide additional information that can be used to help:

  • Screen. Because most tumor markers are not sensitive or specific enough, these tests are not well suited for screening the general population; however, a few may be used to screen people who are at high risk because they have a strong family history or specific risk factors for a particular cancer.
  • Diagnose. In a person who has symptoms, tumor markers may be used to help detect the presence of cancer and help differentiate it from other conditions with similar symptoms.
  • Stage. If a person does have cancer, tumor marker elevations can be used to help determine whether the cancer has spread (metastasized) to other tissues and organs and to what extent.
  • Determine prognosis. Some tumor markers can be used to help determine how aggressive a cancer is likely to be.
  • Guide choice of treatment. A few tumor markers provide information about which treatments might be effective against a person's cancer. This is a growing area of research. For more information, see the article Genetic Tests for Targeted Cancer Therapy.
  • Monitor success of treatment and detect recurrence. Tumor markers can be used to monitor the effectiveness of treatment, especially in advanced cancers. If the marker level drops, the treatment is working; if it stays elevated, adjustments are needed. (The information must be used with care, however, since other conditions can sometimes cause tumor markers to rise or fall.) One of the most important uses for tumor markers, along with guiding treatment, is to monitor for cancer recurrence. If a tumor marker is elevated before treatment, low after treatment, and then begins to rise over time, then it is likely that the cancer is returning. (If it remains elevated after surgery, then chances are that not all of the cancer was removed.)

Examples of tumor markers that are used in each of these ways are provided in the table below.

Table of Examples of Tumor Markers

Tumor markers often have more than one purpose and may be associated with more than one type of cancer. This table lists examples of tumor markers found on this web site and their different uses. Click on the tumor marker to go to the test article for more details on a particular marker.

Tumor marker Associated cancer(s) Usual sample Helps diagnose Stages cancer Determine prognosis Guides treatment Monitors treatment/ detects recurrence Comments
AFP (Alpha-feto protein) Certain liver, ovariantesticular Blood X       X Also elevated during pregnancy and hepatitis 
ALK gene rearrangements Non-small cell lung cancer, anaplastic large cell lymphoma Tissue       X   Helps guide targeted therapy 
B-cell immunoglobulin gene rearrangement B-cell lymphoma Bone marrow, tissue, body fluid, blood X       X Detects characteristic changes in specific genes in B-cells
B2M (Beta-2 microglobulin)

Multiple myeloma, some leukemias, and lymphomas

Blood, urine, CSF     X   X Elevated in other conditions, such as kidney disease
BCR-ABL Chronic myleloid leukemia (CML) and BCR-ABL-positive acute lymphocytic leukemia (ALL) Blood, bone marrow X       X  
CA 15-3 (Cancer antigen 15-3 and CA 27.29 are two different tests for same marker Breast Blood         X Also elevated in other cancers (lungovarian), benign breast conditions, endometriosis, hepatitis
CA 19-9 (Cancer antigen 19-9) Pancreatic, sometimes bile ducts, gallbladder, stomach, colon Blood         X Also elevated in other forms of digestive tract cancer and non-cancer, thyroid diseasepancreatitis, bile duct obstruction, inflammatory bowel disease
CA-125 (Cancer antigen 125) Ovarian Blood X       X Also elevated with other cancers (e.g. endometrial, peritoneal, fallopian tube), PID, uterine fibroids, endometriosis,  pregnancy)
Calcitonin Medullary thyroid carcinoma (MTC) and C-cell hyperplasia Blood X       X Also elevated with other cancers (lung, leukemias, but not used to detect these
CEA (Carcino-embryonic antigen) Colonpancreatic, lung, breast, ovarian, medullary thyroid, others Blood   X X   X Elevated in conditions such as RAhepatitis, COPD, colitis, pancreatitis, and in cigarette smokers
Chromogranin A (CgA) Neuroendocrine tumors (carcinoid tumors, neuroblastoma) Blood X       X May be most sensitive tumor marker for carcinoid tumors
DCP (Des-gamma-carboxy prothrombin) Hepatocellular carcinoma (HCC) Blood         X May be used with imaging study, AFP, AFP-L3%
EGFR mutation Non-small cell lung cancer, sometimes head and neck Tissue     X X   Helps guide targeted therapy 
Estrogen and Progesterone receptors Breast Tissue     X X   Increased in hormone-dependent cancer
Fibrin/Fibrinogen Bladder Urine         X  
Gastrin G-cell hyperplasia, gastrin-producing tumor (gastrinoma) Blood X       X Also used to help diagnose Zollinger-Ellison syndrome
hCG (Human chorionic gonadotropin, also called Beta-hCG) Testicular and trophoblastic disease, germ cell tumors, choriocarcinoma Blood, urine X       X  Elevated in pregnancy
HER2/neu Breast, gastric, esophageal Tissue     X X   Helps guide treatment with drugs that work against HER2 receptors on cancer cells.
JAK2 mutation Certain types of leukemia Blood, bone marrow X         Also used to diagnose myeloproliferative neoplasms (MPNs), especially polycythemia vera (PV)
KRAS mutation Colorectal, non-small cell lung cancer Tissue     X X   Helps guide targeted therapy
LD (Lactate dehydrogenase) Testicular and other germ cell tumors Blood   X X   X Elevated in a wide variety of conditions; may be used in other cancers (e.g. lymphoma, melanoma, neuroblastoma)
Monoclonal immunoglobulins Multiple myeloma and Waldenstroms macroglobulinemia Blood, urine X       X Usually detected by protein electrophoresis or serum free light chains
PSA (Prostate specific antigen) Prostate Blood

X

      X Also elevated in benign prostatic hyperplasia (BPH), prostatitis, may be used for screening
SMRP (Soluble mesothelin-related peptides) Mesothelioma (rare cancer associated with asbestos exposure) Blood         X Often used in conjunction with imaging tests
T-cell receptor gene rearrangement T-cell lymphoma Bone marrow, tissue, body fluid, blood X       X Detects characteristic changes (rearrangements) in specific genes in T-cells
Thyroglobulin Thyroid Blood, tissue         X Used after thyroid is removed to evaluate treatment
21-gene signature (Oncotype DX®) and 70-gene signature (MammaPrint®) Breast Tissue         X Evaluate risk of recurrence

 

View Sources

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used.

Sources Used in Current Review

American Cancer Society. What are tumor markers? Available online at http://www.cancer.org/treatment/understandingyourdiagnosis/examsandtestdescriptions/tumormarkers/tumor-markers-what-are-t-m through http://www.cancer.org. Accessed November. 2013.

American Cancer Society. What's new in tumor marker research? Available online at http://www.cancer.org/treatment/understandingyourdiagnosis/examsandtestdescriptions/tumormarkers/tumor-markers-whats-new through http://www.cancer.org. Accessed November. 2013.

American Cancer Society. Specific tumor markers. Available online at http://www.cancer.org/treatment/understandingyourdiagnosis/examsandtestdescriptions/tumormarkers/tumor-markers-specific-markers through http://www.cancer.org. Accessed November. 2013.

National Cancer Institute. Tumor Markers. Available online at http://www.cancer.gov/cancertopics/factsheet/Detection/tumor-markers through http://www.cancer.gov. Accessed November 2013.

National Comprehensive Cancer Network. Tumor marker. Available online at http://www.nccn.com/component/glossary/Glossary-1/T/Tumor-marker-484/ through http://www.nccn.com. Accessed November 2013.

National Comprehensive Cancer Network. NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology. Available online at http://www.nccn.org/JNCCN/supplements/PDF/TumorMarkers_Task_Force_Report.full.pdf through http://www.nccn.com. Accessed November 2013.

Cancer.Net. Understanding Tumor Markers. Available online at http://www.cancer.net/all-about-cancer/cancernet-feature-articles/treatments-tests-and-procedures/understanding-tumor-markers through http://www.cancer.net. Accessed November 2013.

National Academy of Clinical Biochemistry. Laboratory Medicine Practice Guidelines: Use of Tumor Markers in Clinical Practice: Quality Requirements. Available online through http://www.aacc.org. Accessed November 2013.

Sources Used in Previous Reviews

Thomas, Clayton L., Editor (1997). Taber's Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].

Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby's Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.

ACS (2000 July 19). Tumor Markers. American Cancer Society, Prevention and Early Detection [On-line information]. Available online through http://www.cancer.org.

ACS (1999 July 08). Testing Biopsy and Cytology Specimens for Cancer. American Cancer Society, Prevention and Early Detection [On-line information]. Available online through http://www.cancer.org.

NCI (1998 April 27). Tumor markers. National Cancer Institute, Cancer Facts [On-line information]. Available online at http://cis.nci.nih.gov/fact/5_18.htm through http://cis.nci.nih.gov.

Basquet, C. R. (1995). Cancer and Women. American Medical Women's Association [On-line excerpt from “The American Women’s Association Women's Complete Healthbook,” edited by Epps, R. and Stewart, S.]. Available online at http://www.amwa-doc.org/publications/WCHealthbook/canceramwa-ch37.html through http://www.amwa-doc.org.

Check, W. (1998 July) Reaching agreement on tumor markers. CAP Today, In the News [On-line journal]. Available online at http://www.cap.org/captoday/archive/1998/julycover.html through http://www.cap.org.

Recent Advances (2002 March 11). Gene profiles expose cancer cells' weak points. Dana-Farber Cancer Institute [On-line journal]. Available online at http://www.dana-farber.org/res/research/geneprofiles.asp through http://www.dana-farber.org.

ASCO (1996 May 17). Clinical Practice Guidelines for the Use of Tumor Markers in Breast and Colorectal Cancer. American Society of Clinical Oncology [On-line guidelines]. Available online at http://www.asco.org/prof/pp/html/guide/tumor/m_tumor1.htm through http://www.asco.org.

(1999, Last update) Tumor Marker Tests. University of Iowa Health Care, Holden Comprehensive Cancer Center, Virtual Hospital, the apprentice's assistant [On-line information]. Available online at http://www.vh.org/Patients/IHB/Cancer/Tumormarker.html through http://www.vh.org.

Americna Cancer Society. Tumor Markers. Available online at http://www.cancer.org/docroot/PED/content/PED_2_3X_Tumor_Markers.asp?sitearea=PED through http://www.cancer.org. Accessed Oct 15 2009.

Ask a Laboratory Scientist

 

Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, the American Society for Clinical Laboratory Science (ASCLS). Click on the Contact a Scientist button below to be re-directed to the ASCLS site to complete a request form. If your question relates to this web site and not to a specific lab test, please submit it via our Contact Us page instead. Thank you.

Contact a Scientist